Methods for population-adjusted indirect comparisons in health technology appraisal

DM Phillippo, AE Ades, S Dias… - Medical decision …, 2018 - journals.sagepub.com
Standard methods for indirect comparisons and network meta-analysis are based on
aggregate data, with the key assumption that there is no difference between the trials in the …

NICE DSU technical support document 18: methods for population-adjusted indirect comparisons in submissions to NICE

D Phillippo, T Ades, S Dias, S Palmer, KR Abrams… - 2016 - research-information.bris.ac.uk
Abstract This Technical Support Document examines methods for population-adjusted
indirect comparisons, in which individual patient data (IPD) in one or more trials are used to …

A comparison of relative-efficacy estimate (s) derived from both Matching-Adjusted Indirect Comparisons and Standard Anchored Indirect Treatment Comparisons

O Cassidy, M Harte, L Trela-Larsen, C Walsh, A White… - Value in Health, 2023 - Elsevier
Objectives We present an empirical comparison of relative-efficacy estimate (s) from
Matching-Adjusted Indirect Comparisons (MAICs) with estimates from corresponding …

[HTML][HTML] Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic …

WP Maksymowych, H Thom, MF Mørup, V Taieb… - Rheumatology and …, 2024 - Springer
Introduction A previous network meta-analysis established 16-week relative efficacy with
bimekizumab, an inhibitor of interleukin (IL)-17F in addition to IL-17A, versus other …

[HTML][HTML] Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as assessed by matching-adjusted indirect comparison

WP Maksymowych, V Strand, P Nash… - European Journal of …, 2018 - ncbi.nlm.nih.gov
Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as
assessed by matching-adjusted indirect comparison - PMC Back to Top Skip to main content …

Mirror, mirror, on the wall, which is the most effective biologic of all?

A Deodhar - The Journal of Rheumatology, 2018 - jrheum.org
We all consider the “comparative effectiveness” of available treatment options in daily
clinical practice, knowingly or unknowingly. In fact, that and “comparative safety” are 2 of our …

[HTML][HTML] The need for comparative data in spondyloarthritis

E Choy, X Baraliakos, F Behrens, S D'Angelo… - Arthritis Research & …, 2019 - Springer
Spondyloarthritis comprises a group of inflammatory diseases, characterised by
inflammation within axial joints and/or peripheral arthritis, enthesitis and dactylitis. An …

[HTML][HTML] Результаты оценки сравнительной эффективности применения секукинумаба и адалимумаба в лечении псориатического артрита с использованием …

ТВ Коротаева - Современная ревматология, 2016 - cyberleninka.ru
Интенсивное изучение патогенеза ревматических заболеваний позволяет выявить все
новые и новые мишени для таргетного терапевтического воздействия, соответственно …

Results of evaluating the efficacy of secukinumab versus adalimumab in treating psoriatic arthritis by using the matching-adjusted indirect comparison method

TV Korotaeva - Modern Rheumatology Journal, 2016 - mrj.ima-press.net
RESULTS OF EVALUATING THE EFFICACY OF SECUKINUMAB VERSUS ADALIMUMAB IN
TREATING PSORIATIC ARTHRITIS BY USING THE MATCHING-ADJUSTED INDIRECT …

Eficacia y seguridad de los fármacos inhibidores de la interleucina-17 en la espondilitis anquilosante

V Navarro-Compán - Reumatol. clin., Supl.(Barc.), 2018 - pesquisa.bvsalud.org
La IL-17 es una citocina proinflamatoria clave en la patogénesis de la espondilitis
anquilosante que ha surgido recientemente como una diana prometedora para el …